首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer investigation

缩写:CANCER INVEST

ISSN:0735-7907

e-ISSN:1532-4192

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1677条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yuqi Sheng,Yuwei Yang,Ruizhe Zhang et al. Yuqi Sheng et al.
Spatial transcriptomics (ST) is revolutionizing pan-cancer analysis by enabling the in situ integration of spatial architecture with molecular profiles. This review synthesizes key advances, including deciphering conserved and divergent spa...
Uchechukwu C Megwalu,Yifei Ma Uchechukwu C Megwalu
There are significant racial and ethnic disparities in head and neck cancer (HNC) survival. Disparities in cancer stage appear to account for some of the disparities in survival. However, the proportion of the survival disparities mediated ...
Kunhong Tang,Wei Zheng Huang,Jiaqi Wei et al. Kunhong Tang et al.
This meta-analysis integrates data from 7 randomized controlled trials comprising 4,560 patients with advanced gastric cancer to evaluate the efficacy and safety of pembrolizumab as monotherapy or in combination with chemotherapy. Compared ...
Binghai Li,Dan Li,Ningning Deng et al. Binghai Li et al.
Disitamab vedotin (RC48), a HER2-targeted antibody-drug conjugate, has shown promising activity in locally advanced or metastatic urothelial carcinoma (la/mUC), but clinically useful biomarkers remain lacking. In this retrospective single-c...
Azhar Mehmood,Ishrat Mahjabeen,Asif Nisar et al. Azhar Mehmood et al.
Background: Breast cancer burden is increasing day by day. The identification of novel genetic markers based on polymorphism and expression analysis is necessary to reduce the suffering of patients. ...
Erhao Bao,Yuchen Li,Yang Yang et al. Erhao Bao et al.
Background: Cabozantinib is a multi-target tyrosine kinase inhibitor widely used in advanced renal cell carcinoma (RCC). However, real-world evidence regarding its safety profile, particularly sex-specific adverse events ...
Eliganti Ramalakshmi,Loshma Gunisetti,Sumalatha Lingamgunta Eliganti Ramalakshmi
One of the main reasons for the high death rate in today's world is Breast Cancer (BC), which affects women all over the world. This work proposes a novel Parallel Convolutional-LeNet (PConv-LeNet) technique for BC detection and classificat...
Gianluca Ciarlo,Lena Josfeld,Jutta Hübner Gianluca Ciarlo
Many cancer patients use complementary and alternative medicine (CAM), often seeking a more holistic approach. This study explored whether patients have different communication expectations for oncologists and any professional provider of C...